ArticleTrials2020

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.

Nisha R Acharya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.